• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部放疗后出现严重的口干、吞咽困难和颈部纤维化。

Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.

机构信息

Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.

Faculty of Medicine and Health Sciences, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

出版信息

Head Neck. 2019 Oct;41(10):3594-3603. doi: 10.1002/hed.25880. Epub 2019 Jul 22.

DOI:10.1002/hed.25880
PMID:31329343
Abstract

BACKGROUND

Acute and late toxicity after intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC) impacts on patient quality of life; yet, very late toxicity data remain scarce. This study assessed dysphagia, xerostomia, and neck fibrosis 3-8 years after IMRT.

METHODS

A retrospective analysis using generalized estimated equations was performed on 60 patients with HNC treated with fractionated IMRT between 2000 and 2015 who had a follow-up ≥8 years. Toxicity was scored using LENT-SOMA scales.

RESULTS

A trend towards a nonlinear global time effect (P = .05) was noted for dysphagia with a decrease during the 5 years post-treatment and an increase thereafter. A significant decrease in xerostomia (P = .001) and an increase in neck fibrosis (P = .04) was observed until 8 years.

CONCLUSIONS

Dysphagia, xerostomia, and neck fibrosis do not appear stable over time and remain highly prevalent in the very late follow-up. Our findings support the need for prospective trials investigating very late toxicity in patients with HNC.

摘要

背景

头颈部癌症(HNC)调强放疗(IMRT)后的急性和晚期毒性会影响患者的生活质量;然而,非常晚期的毒性数据仍然很少。本研究评估了 IMRT 治疗后 3-8 年的吞咽困难、口干和颈部纤维化。

方法

对 2000 年至 2015 年间接受分割 IMRT 治疗的 60 例 HNC 患者进行了回顾性分析,这些患者的随访时间≥8 年。采用 LENT-SOMA 量表对毒性进行评分。

结果

吞咽困难的整体时间效应呈非线性趋势(P =.05),治疗后 5 年内下降,此后上升。观察到口干(P =.001)显著下降和颈部纤维化(P =.04)增加,直到 8 年。

结论

吞咽困难、口干和颈部纤维化随时间推移似乎并不稳定,在非常晚期随访中仍高度普遍。我们的研究结果支持需要进行前瞻性试验,以研究 HNC 患者的非常晚期毒性。

相似文献

1
Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.头颈部放疗后出现严重的口干、吞咽困难和颈部纤维化。
Head Neck. 2019 Oct;41(10):3594-3603. doi: 10.1002/hed.25880. Epub 2019 Jul 22.
2
Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.全野序贯调强放疗用于局部区域晚期头颈部鳞状细胞癌
Am J Clin Oncol. 2015 Dec;38(6):588-94. doi: 10.1097/COC.0000000000000001.
3
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.调强放射治疗可降低放射诱导的发病率并改善健康相关生活质量:一项使用标准化随访方案的非随机前瞻性研究结果
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.
4
Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.调强放疗在 IV 期头颈部鳞状细胞癌中的价值。
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1373-80. doi: 10.1016/j.ijrobp.2009.10.018. Epub 2010 Apr 1.
5
Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.调强放疗治疗不明原发灶头颈部肿瘤的剂量学和临床疗效改善。
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):756-62. doi: 10.1016/j.ijrobp.2009.11.020. Epub 2010 Apr 24.
6
Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.原发灶不明的颈部淋巴结转移癌的调强放疗:单中心经验。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1866-71. doi: 10.1016/j.ijrobp.2011.02.031. Epub 2011 Apr 15.
7
Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.未知原发灶头颈部癌患者调强放疗全黏膜照射:两项前瞻性研究的汇总分析
Clin Oncol (R Coll Radiol). 2016 Sep;28(9):e77-e84. doi: 10.1016/j.clon.2016.04.035. Epub 2016 May 11.
8
Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy.调强放射治疗局部晚期头颈癌患者口干症的客观与主观评估
J Cancer Res Ther. 2018 Oct-Dec;14(6):1196-1201. doi: 10.4103/jcrt.JCRT_200_17.
9
Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.局部晚期头颈癌加速调强放射治疗的物理和放射生物学评估及其与短期临床结果的比较。
Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2463-2470. doi: 10.31557/APJCP.2019.20.8.2463.
10
Patterns of failure, treatment outcomes and late toxicities of head and neck cancer in the current era of IMRT.调强放疗时代头颈部癌症的失败模式、治疗结果和晚期毒性。
Oral Oncol. 2018 Nov;86:225-233. doi: 10.1016/j.oraloncology.2018.09.011. Epub 2018 Oct 4.

引用本文的文献

1
Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis.头颈癌长期幸存者的毒性——一项多国横断面分析。
Int J Cancer. 2025 Nov 15;157(10):2061-2070. doi: 10.1002/ijc.70033. Epub 2025 Jul 30.
2
Potential role of photobiomodulation as a prevention and treatment strategy for radiation induced fibrosis: a review of effectiveness and mechanisms.光生物调节作为放射性纤维化预防和治疗策略的潜在作用:有效性和机制综述
PeerJ. 2025 Jun 2;13:e19494. doi: 10.7717/peerj.19494. eCollection 2025.
3
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors.
头颈部癌症幸存者长期使用饲管——患者及治疗相关因素分析
Int J Radiat Oncol Biol Phys. 2025 Jun 3. doi: 10.1016/j.ijrobp.2025.05.064.
4
Late radiation-associated dysphagia following treatment for head and neck cancer: a scoping review.头颈部癌治疗后迟发性放射性吞咽困难:一项范围综述
Support Care Cancer. 2025 May 22;33(6):493. doi: 10.1007/s00520-025-09540-4.
5
Acoustic Features of Airway Protective Maneuvers as Biomarkers of Radiation-Associated Dysphagia and Penetration/Aspiration in Head and Neck Cancer Patients.气道保护动作的声学特征作为头颈癌患者放射性吞咽困难及误吸/渗透的生物标志物
Head Neck. 2025 Sep;47(9):2464-2485. doi: 10.1002/hed.28163. Epub 2025 Apr 16.
6
Disparities in Dysphagia Care Among Head and Neck Cancer Patients: A Retrospective Cohort Study.头颈癌患者吞咽困难护理的差异:一项回顾性队列研究
OTO Open. 2025 Apr 11;9(2):e70090. doi: 10.1002/oto2.70090. eCollection 2025 Apr-Jun.
7
Radiation-Therapy Related Salivary Dysfunction.放射治疗相关的唾液腺功能障碍
Semin Radiat Oncol. 2025 Apr;35(2):278-284. doi: 10.1016/j.semradonc.2025.02.006.
8
Oral microbiota in head and neck cancer patients during radiotherapy: a systematic review.头颈部癌症患者放疗期间的口腔微生物群:一项系统综述
Support Care Cancer. 2025 Jan 29;33(2):127. doi: 10.1007/s00520-025-09191-5.
9
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study.多维度疲劳及其对口咽癌根治性调强放疗长期幸存者工作效率、情绪和生活质量的影响:一项横断面研究。
J Cancer Surviv. 2025 Jan 18. doi: 10.1007/s11764-024-01735-8.
10
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Cancer.新辅助化疗与经口机器人手术治疗人乳头瘤病毒相关口咽癌
JAMA Otolaryngol Head Neck Surg. 2025 Feb 1;151(2):128-134. doi: 10.1001/jamaoto.2024.3303.